302 related articles for article (PubMed ID: 31381187)
21. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG
BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Whole Blood and Plasma for Monitoring Cytomegalovirus and Epstein-Barr Virus.
Fukuda Y; Torii Y; Iwata KI; Haruta K; Yamaguchi M; Suzuki T; Narita A; Muramatsu H; Ogura Y; Takahashi Y; Ito Y; Kawada JI
New Microbiol; 2024 May; 47(1):52-59. PubMed ID: 38700884
[TBL] [Abstract][Full Text] [Related]
23. Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.
Havenith SH; Remmerswaal EB; Bemelman FJ; Yong SL; van Donselaar-van der Pant KA; van Lier RA; Ten Berge IJ
Clin Exp Immunol; 2012 Sep; 169(3):292-301. PubMed ID: 22861369
[TBL] [Abstract][Full Text] [Related]
24. Subclinical Cytomegalovirus and Epstein-Barr Virus Shedding Is Associated with Increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
Chaillon A; Nakazawa M; Rawlings SA; Curtin G; Caballero G; Scott B; Anderson C; Gianella S
J Virol; 2020 Sep; 94(19):. PubMed ID: 32641485
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
[TBL] [Abstract][Full Text] [Related]
26. Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease.
Ohga S; Kubo E; Nomura A; Takada H; Suga N; Ishii E; Suminoe A; Inamitsu T; Matsuzaki A; Kasuga N; Hara T
Int J Hematol; 2001 Apr; 73(3):323-6. PubMed ID: 11345197
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological and Liver Biomarkers Profile of Epstein-Barr Virus Infection and Its Coinfection with Cytomegalovirus in Patients with Hematological Diseases.
Ferrari de Freitas L; de Melo Silva J; Nogueira Barbosa A; Miranda Santos E; Pinheiro-Silva R; Soares Pontes G
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439817
[TBL] [Abstract][Full Text] [Related]
28. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.
Hornef MW; Bein G; Fricke L; Steinhoff J; Wagner HJ; Hinderer W; Sonneborn HH; Kirchner H
Transplantation; 1995 Sep; 60(5):474-80. PubMed ID: 7676497
[TBL] [Abstract][Full Text] [Related]
29. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
[TBL] [Abstract][Full Text] [Related]
31. Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy.
Hatayama Y; Hashimoto Y; Motokura T
J Int Med Res; 2020 Nov; 48(11):300060520972880. PubMed ID: 33249964
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
[TBL] [Abstract][Full Text] [Related]
33. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
[TBL] [Abstract][Full Text] [Related]
34. [How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].
Brissot E; Alsuliman T; Gruson B; Hermet E; Tirefort Y; Yakoub-Agha I; Alain S
Bull Cancer; 2017 Dec; 104(12S):S181-S187. PubMed ID: 29169653
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
36. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia.
Sakamoto T; Obara N; Maruyama Y; Kato T; Kurita N; Hattori K; Suehara Y; Nishikii H; Yokoyama Y; Sakata-Yanagimoto M; Usuki K; Chiba S
Eur J Haematol; 2023 Nov; 111(5):768-776. PubMed ID: 37549934
[TBL] [Abstract][Full Text] [Related]
37. Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation.
Li SS; Zhang N; Jia M; Su M
Front Cell Infect Microbiol; 2022; 12():818167. PubMed ID: 35402291
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β- and CD19-Depleted Grafts.
Laberko A; Bogoyavlenskaya A; Shelikhova L; Shekhovtsova Z; Balashov D; Voronin K; Kurnikova E; Boyakova E; Raykina E; Brilliantova V; Pirumova V; Novichkova G; Maschan A; Maschan M
Biol Blood Marrow Transplant; 2017 Mar; 23(3):483-490. PubMed ID: 28039080
[TBL] [Abstract][Full Text] [Related]
39. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
Barkholt L; Linde A; Falk KI
Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
[TBL] [Abstract][Full Text] [Related]
40. Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy.
Kawarada Y; Hara R; Kitahara T; Numata H; Watanabe S; Yamada M; Ando K
Intern Med; 2023 Sep; 62(17):2553-2557. PubMed ID: 36725050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
